Nadroparin Calcium

CHEMBL2109204 Phase 4 Одобрено Oligosaccharide
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
— g/mol
LogP
—
Phase
4

A calcium salt form of nadroparin, sharing the same therapeutic uses.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Часто задаваемые вопросы

A calcium salt form of nadroparin, sharing the same therapeutic uses.

Yes, Nadroparin Calcium is an approved drug. It has reached clinical phase 4. It is classified as a Oligosaccharide.

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2109204. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

Медицинский отказ от ответственности

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.